Xenetic biosciences, inc. (XBIO)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Nov'13Aug'13Jun'13May'13Mar'13Feb'13Nov'12Aug'12May'12Feb'12Nov'11
Revenue
Collaboration services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenues

0

-

-

-

0

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

33

66

96

0

131

0

128

132

112

0

0

0

Gross profit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

0

0

-

-

-

0

-

-

Operating costs and expenses:
Cost of research and development revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of research and development revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of research and development revenue

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

0

-

-

-

-

-

-

Cost of research and development revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

0

-

-

Research and development

4,785

4,889

4,986

2,201

2,641

2,883

3,449

3,598

3,545

4,060

43,191

43,198

44,529

43,737

4,553

4,477

2,828

3,434

5,228

6,317

6,794

6,323

0

0

0

-

-

0

-

0

-

-

-

-

-

-

General and administrative

4,795

4,731

5,021

3,957

4,133

4,392

5,256

5,521

6,425

6,937

7,301

7,317

6,904

6,692

6,004

7,629

6,875

6,388

6,119

4,338

5,141

6,600

0

0

0

-

-

0

-

0

-

-

-

-

-

-

Goodwill impairment

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Aircraft maintenance and fee

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2

9

-

16

-

32

44

36

0

0

0

Fuel and oil

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3

8

-

15

-

25

37

27

0

0

0

Management fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

0

-

-

-

-

Management fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

-

0

0

0

Officer compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

0

-

-

Professional fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

131

78

-

91

-

102

116

126

0

0

0

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

0

-

-

-

-

Administrative fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

0

-

-

-

-

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

-

0

0

0

Administrative fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

-

0

0

0

Total operating costs and expenses

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,141

197

162

0

165

0

197

245

229

0

0

0

Loss from operations

-12,790

-12,886

-13,291

-6,159

-6,775

-7,276

-1,206

-1,631

-2,541

-3,568

-8,064

-8,075

-48,434

-47,430

-50,057

-51,607

-9,703

-9,822

-11,347

-10,655

-11,935

-12,924

-8,784

-5,737

-3,108

-131

-65

0

-43

0

-68

-113

-116

0

0

0

Other income (expense):
Change in fair value of derviative liability

-

-

-

-

-

-

-

-

-

-

-

-

-

2,125

1,366

-219

-1,989

-2,125

-1,344

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on issuance of hybrid debt instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,690

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on issuance of hybrid debt instrument

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on conversion of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of subsidiaries

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

0

-

-

-

-

-

-

-

-

Other expense

3

3

0

2

-30

-24

-16

-33

-26

-41

-107

-106

-68

-85

0

0

0

-

0

0

-

-326

0

0

0

-

-

0

-

0

-

-

-

-

-

-

Interest income, net

159

108

47

0

0

0

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-26

-23

-

-12

-

-12

-12

-13

0

0

0

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1

1

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

729

826

612

511

266

0

0

0

-

-

-6

-11

-15

-12

0

-12

-

-12

-12

-13

0

0

0

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

0

-

0

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income (expense)

163

111

47

3

-30

-24

-9

-27

-10

-26

-367

-572

-5,065

-6,775

-7,384

-8,686

-3,944

-2,685

-1,835

-386

-739

-1,382

0

0

0

-

-

0

-

-

-

-

-

-

-

-

Loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

-

0

-

-

-

-

-

-

Income tax

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

-

0

-

-

-

-

-

-

Net loss

-12,627

-12,775

-13,244

-6,156

-6,805

-7,300

-1,215

-1,659

-2,552

-3,595

-8,431

-8,647

-53,500

-54,206

-57,442

-60,293

-13,647

-12,507

-13,183

-11,041

-12,675

-14,307

0

0

0

-

-

-

-

-

-

-

-

-

-

-

Deemed dividend

1,404

5,284

5,284

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deemed dividend

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss applicable to common stockholders

-14,032

-18,059

-18,528

-10,035

-10,684

-7,300

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

-

-

-

-

-

Other comprehensive loss from foreign currency translation adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-321

-628

-1,175

-438

-324

0

0

0

-

-

0

-

0

-

-

-

-

-

-

Total comprehensive loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-12,829

-13,811

-12,216

-13,113

-14,631

0

0

0

-

-

0

-

0

-

-

-

-

-

-

Net income (loss)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-157

-89

-

-56

-

-81

-125

-129

0

0

0

Basic and diluted loss per share

-0.19

4.35

-2.67

-1.56

-6.45

-4.36

-2.31

-2.78

-0.21

0.53

-0.26

-0.34

-0.34

-0.66

-0.28

-6.12

-0.78

-

-1.26

-0.27

-

-0.04

-0.02

-0.02

-0.03

0.00

0.00

-0.01

0.00

-0.01

0.00

-0.00

-0.01

0.00

0.00

0.00

Weighted-average shares of common stock outstanding, basic and diluted

6,233

5,857

3,862

882

806

-7,206

783

728

8,717

8,720

8,717

8,706

8,518

8,339

8,987

7,804

4,591

-

4,228

4,221

-

135,426

136,052

136,052

136,052

-

-

119,831

-

119,831

-

-

-

-

-

-

Weighted average shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

135,000

256,500

-

135,000

-

135,000

13,500

345,307

121,304

100,000

10,000

Royalty [Member]
Total revenues

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-